Fatty Acid Escape Hypothesis: The Pathway to Type-2 Diabetes
DOI:
https://doi.org/10.17140/DROJ-5-140Keywords:
Adipose tissue Diabetes, Fatty acid Insulin, Resistance ObesityAbstract
Obesity and Type 2 diabetes mellitus (T2DM) are closely related such that together these are generally called diabesity, the underlying
causes of which revolve around the functioning of insulin. Methods PubMed was searched using the following Mesh [(“Adipocytes/classification”[Mesh] OR “Adipocytes/cytology”[Mesh] OR “Adipocytes/ metabolism”[Mesh] OR “Adipocytes/pathology” [Mesh] OR “Adipocytes/physiology”[Mesh]) OR “Fatty acids (FA)” [Mesh]. Results The interaction of insulin with the whole body systems is extensive and resistance to insulin can occur due to multiple reasons including sepsis, Cushing’s syndrome, or even with pregnancy. In this review of literature, our focus is primarily on insulin resistance that is associated with obesity. Insulin promotes lipogenesis in the liver and promotes glucose uptake by skeletal muscles and adipose tissues. Also, insulin inhibits lipolysis in adipose tissue to allow triacylglycerides (TAG) storage in the anhydrous droplet form. When insulin resistance ensues, the delicate balance will tilt to a self-enabling cycle that culminates in the development of T2DM “Diabesity”. Conclusion This review of literature also discusses the hypothetical cascade of defective expansion of adipose tissue due to fatty acids escape, chronic inflammatory state, and ectopic fat deposition in the omentum, liver and skeletal muscles that underlie the pathogenesis of this disease process.
References
World Health Organization (WHO). Diabetes. Global report on diabetes. Web site. http://www.who.int/diabetes/global-report/
World Health Organization (WHO). Obesity and overweight. Web site. http://www.who.int/mediacentre/factsheets/fs311/en/
Das AK, Shah S. History of diabetes: from ants to analogs. J Assoc Phys India. 2011; 59 Suppl: 6-7.
Templeman NM, Skovso S, Page MM, Lim GE, Johnson JD. A causal role for hyperinsulinemia in obesity. J Endocrinol. 2017; 232(3): R173-R183. doi: 10.1530/JOE-16-0449
Mehran AE, Templeman NM, Brigidi GS, et al. Hyperinsu-linemia drives diet-induced obesity independently of brain insu-lin production. Cell Metab. 2012; 16(6): 723-733. doi: 10.1016/j. cmet.2012.10.019
D’souza AM, Johnson JD, Clee SM, Kieffer TJ. Suppressing hy-per-insulinemia prevents obesity but causes rapid onset of diabetes in leptin-deficient Lepob/ob mice. Mol Metab. 2016; 5: 1103-1112. doi: 10.1016/j.molmet.2016.09.007
Odeleye OE, de Courten M, Pettitt DJ, Ravussin E. Fasting hy-perinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes. 1997; 46(8): 1341-1345. doi: 10.2337/diabetes.46.8.1341
Schonfeld P, Wojtczak L. Short- and medium-chain fatty acids in the energy metabolism – the cellular perspective. J Lipid Res. 2016; 57: 943-954. doi: 10.1194/jlr.R067629
Yasuaki I, Yuji K, Masataka H, et al. Free fatty acids regulate in-sulin secretion from pancreatic beta cells through GPR40. Nature. 2003; 422(69280): 173-176. doi: 10.1038/nature01478
McGarry JD, Dobbins RL. Fatty acid, lipotoxicity and in-sulin secretion. Diabetologia. 1999; 42: 128-138. doi: 10.1007/ s001250051130
Gravena C, Mathias PC, Ashcroft SJH. Acute effects of fatty acids on insulin secretion from rat and human islets of Langer-hans. J Endocrinol. 2002; 173: 73-80.
Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest. 1994; 93(6): 2438-2446. doi: 10.1172/JCI117252
Randle PJ, Garland PB, Hales CN, Newsholme EA. The glu-cose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963; 1: 785-789. doi: 10.1016/S0140-6736(63)91500-9
Randle PJ, Garland PB, Newsholme EA, Hales CN. The glu-cose fatty acid cycle in obesity and maturity onset diabetes mel-litus. Ann NY Acad Sci. 1965; 131: 324-333. doi: 10.1111/j.1749- 6632.1965.tb34800.x
Roden M. How free fatty acids inhibit glucose utilization in hu-man skeletal muscle. News Physiol Sci. 2004; 19: 92-96. doi: 10.1152/ nips.01459.2003
Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid–induced insulin resistance in humans. J Clin Invest. 1996; 97(12): 2859-2865. doi: 10.1172/JCI118742
Sears B, Perry M. The role of fatty acids in insulin resistance. Lipids Health Dis. 2015; 14: 121. doi: 10.1186/s12944-015-0123-1
Mäkinen S, Nguyen YH, Skrobuk P, Koistinen HA. Palmitate and oleate exert differential effects on insulin signaling and glucose uptake in human skeletal muscle cells. Endocrine Connections. 2017; 6: 331-339. doi: 10.1530/EC-17-0039
Wolfe BM, Klein S, Peters EJ, Schmidt BF, Wolfe RR. Ef-fect of elevated free fatty acids on glucose oxidation in normal humans. Metabolism.1988; 37(4): 323-329. doi: 10.1016/0026- 0495(88)90131-X
Kelley DE, Mokan M, Simoneau JA, Mandarino LJ. Interac-tionbetween glucose and free fatty acid metabolism in human skel-etal muscle. J Clin Invest. 1993; 92: 91-98. doi: 10.1172/JCI116603
Lv ZH, Ma P, Luo W, et al. Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction. BMC Cardiovasc Disord. 2014; 14: 159. doi: 10.1186/1471-2261-14-159
Cefalu WT. Insulin resistance: Cellular and clini-cal concepts. Exp Biol Med (Maywood). 2001; 226: 13-26. doi: 10.1177/153537020122600103
Rosen ED, Spiegelman BM. Adipocytes as regulators of en-ergy balance and glucose homeostasis. Nature. 2006; 444(7121): 847-853. doi: 10.1038/nature05483
Gagnon A, Sorisky A. The effect of glucose concentration on insulin-induced 3T3-L1 adipose cell differentiation.Obes Res. 1998; 6(2): 157-163. doi: 10.1002/j.1550-8528.1998.tb00330.x
Palacios-Ortega S, Varela-Guruceaga M, Martínez JA, de Miguel C, Milagro FI. Effects of high glucose on caveolin-1 and insulin signaling in 3T3-L1 adipocytes. Adipocytes. 2016; 5(1): 65-80. doi: 10.1080/21623945.2015.1122856
Lin Y, Berg AH, Iyengar P, et al. The hyperglycemia-induced inflammatory response in adipocytes: The role of reactive oxy-gen species. J Biol Chem. 2005; 280: 4617-4626. doi: 10.1074/jbc. M411863200
Riley CL, Bout D, Bean C, et al. UCP1 is essential for mito-chondrial structural integrity and function in brown adipose tissue. FASEB J. 2017; 31(1).
Rocchi S, Tartare-Deckert S, Mothe I, van Obberghen E. Iden-tification by mutation of the tyrosine residues in the insulin recep-tor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase. Endocrinol. 1995; 136: 5291- 5297. doi: 10.1210/endo.136.12.7588273
Bouzakri K, Roques M, Gual P, et al. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphory-lation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes. 2003; 52: 1319-1325. doi: 10.2337/diabetes.52.6.1319
Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. Mea-surement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes. 1988; 37(8): 1020-1024. doi: 10.2337/diabetes.37.8.1020
Spalding KL, Bhardwaj RD, Buchholz BA, Druid H, Frisen J. Retrospective birth dating of cells in humans. Cell. 2005; 122: 133- 143. doi: 10.1016/j.cell.2005.04.028
Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature. 2008; 453: 783-787. doi: 10.1038/ nature06902
Olokoba AB, Obateru OA, Olokoba LB. Type 2 Diabetes mel-litus: A review of current trends. Oman Med J. 2012; 27(4): 269-273. doi: 10.5001/omj.2012.68
Yin X, Lanza IR, Swain JM, Sarr MG, Nair SK, Jensen MD. Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. J Clin Endocrin Metab. 2014; 99: E209- E216. doi: 10.1210/jc.2013-3042
Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Ann Rev Biochem. 1997; 66: 581-611. doi: 10.1146/annurev.biochem.66.1.581
Franckhauser S, Muñoz S, Pujol A, et al. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes. 2002; 51(3): 624-630. doi: 10.2337/diabetes.51.3.624
Hakimi P, Johnson MT, Yang J, et al. Phosphoenolpyruvate carboxykinase and the critical role of cataplerosis in the con-trol of hepatic metabolism. Nutr Metab (Lond). 2005; 2: 33. doi: 10.1186/1743-7075-2-33
Brun T, Scarcia P, Li N, et al. Changes in mitochondrial car-riers exhibit stress-specific signatures in INS-1Eβ-Cells exposed to glucose versus fatty acids. PLoS One. 2013; 8(12): e82364. doi: 10.1371/journal.pone.0082364
Das K, Lewis RY, Combatsiaris TP, et al. Predominant expres-sion of the mitochondrial dicarboxylate carrier in white adipose tissue. Biochem J. 1999; 344(2): 313-320.
Arner P. The adipocyte in insulin resistance: Key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab. 2003; 14(3): 137-145. doi: 10.1016/S1043-2760(03)00024-9
Kim JI, Huh JY, Sohna JH, et al. Lipid-overloaded enlarged adi-pocytes provoke insulin resistance independent of inflammation. Mol Cell Biol. 2015; 35(10): 1686-1699. doi: 10.1128/MCB.01321-
Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care. 2007; 10(2): 142-148. doi: 10.1097/ MCO.0b013e328042ba90
Paz K, Hemi R, LeRoith R, et al. Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase b positively regulates irs-1 function. J Biol Chem. 1997; 272: 29911-29918.
Liu YF, Paz K, Herschkovitz A, et al. Protein kinase c θ inhibits insulin signaling by phosphorylating irs1 at Ser1101. J Biol Chem. 2001; 276: 14459-14465. doi: 10.1074/jbc.C400186200
Ohmura E, Hosaka D, Yazawa M, et al. Association of free fatty acids (FFA) and tumor necrosis factor-alpha (TNF-alpha) and insulin-resistant metabolic disorder. Horm Metab Res. 2007; 39(3): 212-217. doi: 10.1055/s-2007-970421
Mlinar B, Marc J, Pfeifer M. Molecular mechanisms of insu-lin resistance, obesity and metabolic syndrome. Bio chemia Medica. 2006; 16(1): 8-24. doi: 10.11613/BM.2006.003
Le Roith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care. 2001; 24(3): 588- 597. doi: 10.2337/diacare.24.3.588
Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. Adipose tissue remodeling: its role in energy metabolism and metabolic disor-ders. Front Endocrinol (Lausanne). 2016; 7: 30. doi: 10.3389/fen-do.2016.00030
Rutkowski JM, Stern JH, Scherer PE. The cell biology of fat expansion. J Cell Biol. 2015; 208(5): 501-512. doi: 10.1083/ jcb.201409063
Park S-H, Liu Z, Sui Y, et al. IKKb is essential for adipocyte survival and adaptive adipose remodeling in obesity. Diabetes. 2016; 65: 1616-1629. doi: 10.2337/db15-1156
Ye J. Emerging role of adipose tissue hypoxia in obesity and in-sulinresistance. Int J Obes (Lond). 2009; 33(1): 54-66. doi: 10.1038/ Systematic Review based Hypothesis | Volume 5 | Number 1| Haider KhH, et al ijo.2008.229
Jiang C, Qu A, Matsubara T, et al. Disruption of hypoxia-in-ducible factor 1 in Adipocytes improves insulin sensitivity and de-creases adiposity in high-fat diet–fed mice. Diabetes. 2011; 60(10): 2484-2495. doi: 10.2337/db11-0174
Martinez-Santibañez G, Lumeng CN-K. Macrophages and the regulation of adipose tissue remodeling. Annu Rev Nutr. 2014; 34(1): 57-76. doi: 10.1146/annurev-nutr-071812-161113
Guzik TJ, Skiba DS, Touyz RM, Harrison DG. The role of infiltrating immune cells in dysfunctional adipose tissue. Cardiovasc Res. 2017; 113(9): 1009-1023. doi: 10.1093/cvr/cvx108
Kang YE, Kim JM, Joung KH, et al. The roles of adipokines, pro-inflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic dysfunction. PLoS One. 2016; 11(4): e0154003. doi: 10.1371/journal.pone.0154003
Ibrahim MM. Subcutaneous and visceral adipose tissue: struc-tural and functional differences. Obes Rev. 2010; 11(1): 11-18. doi: 10.1111/j.1467-789X.2009.00623.x
Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: The paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006; 2(4): 367-373. doi: 10.2174/1573399810602040367
Lafontan M. Differences between subcutaneous and visceral adipose tissues. [In:] Bastard JP, Fève B (eds). Physiology and Phys-iopathology of Adipose Tissue. New York City, USA: Springer. 2013. 329-349.
Andersson DP. Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss. Diabetes Care. 2014; 37(7): 1831- 1836. doi: 10.2337/dc13-2395
Preis SR, Massaro JM, Robins SJ, et al. Abdominal subcutane-ous and visceral adipose tissue and insulin resistance in the Fram-ingham heart study. Obesity (Silver Spring). 2010; 18(11): 2191-2198. doi: 10.1038/oby.2010.59
Fang L, Guo F, Zhou L, Stahl R, Grams J. The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans. Adipocyte. 2015; 4(4): 273-279. doi: 10.1080/21623945.2015.1034920
Jocken JW, Blaak EE. Catecholamine-induced lipolysis in adi-pose tissue and skeletal muscle in obesity. Physiol Behav. 2008; 94(2): 219-230. doi: 10.1016/j.physbeh.2008.01.002
Thompson D, Karpe F, Lafontan M, Frayn K. Physical activity and exercise in the regulation of human adipose tissue physiology. Physiol Rev. 2012; 92(1): 157-191. doi: 10.1152/physrev.00012.2011
Gerhard GS, Styer AM, Strodel WE, et al. Gene expression profiling in subcutaneous, visceral, and epigastric adipose tissues of patients with extreme obesity. Int J Obes (Lond). 2014; 38(3): 371- 378. doi: 10.1038/ijo.2013.152
Ruge T, Sukonina V, Myrnas T, et al. Lipoprotein lipase ac-tivity/mass ratio is higher in omental than in subcutaneous adi-pose tissue. Eur J Clin Invest. 2006; 36: 16-21. doi: 10.1111/j.1365- 2362.2006.01584.x
Fried SK, Russell CD, Grauso NL, Brolin RE. Lipoprotein li-pase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest. 1993; 92: 2191-2198. doi: 10.1172/JCI116821
Semenkovich CF, Wims M, Noe L, Etienne J, Chan L. Insu-lin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J Biol Chem. 1989; 264: 9030-9038.
Faraj M, Sniderman AD, Cianflone K. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adi-pocytes. J Lipid Res. 2004; 45: 657-666. doi: 10.1194/jlr.M300299- JLR200
Mashek DG. Hepatic fatty acid trafficking: Multiple forks in the road. Adv Nutr. 2013; 4: 697-710. doi: 10.3945/an.113.004648
Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H. Increased liver fat, impaired insulin clearance, and he-patic and adipose tissue insulin resistance in type 2 diabetes. Gastro-enterology. 2008; 135(1): 122-130. doi: 10.1053/j.gastro.2008.03.021
Badin P-M, Langin D, Moro C. Dynamics of skeletal muscle Submit your article to this journal | https://openventio.org/submit-manuscript/ lipid pools. Trends Endocrinol Metab. 2013; 24(12): 589-644. doi: 10.1016/j.tem.2013.08.001
Shaw CS, Clark J, Wagenmakers AJ. The effect of exercise and nutrition on intramuscular fat metabolism and insulin sen-sitivity. Ann Rev Nut. 2010; 30(1): 13-34. doi: 10.1146/annurev. nutr.012809.104817
Dagenais GR, Tancredi RG, Zierler KL. Free fatty acid oxida-tion by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. J Clin Invest. 1976; 58: 421-431. doi: 10.1172/JCI108486
Guo Z, Burguera B, Jensen MD. Kinetics of intramuscular triglyceride fatty acids in exercising humans. J Appl Physiol (1985). 2000; 89: 2057-2064. doi: 10.1152/jappl.2000.89.5.2057
Schenk S, Horowitz JF. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insu-lin resistance. J Clin Invest. 2007; 117(6): 1690-1698. doi: 10.1172/ JCI30566
Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: Evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab. 2001; 86(12): 5755-5761. doi: 10.1210/jcem.86.12.8075
Li Y, Xu S, Zhang X, Zongchun Y, Cichello S. Skeletal intra-myocellular lipid metabolism and insulin resistance. Biophys Rep. 2015; 1: 90-98. doi: 10.1007/s41048-015-0013-0
Hansen ME, Tippett TS. Insulin increases ceramide syn-thesis in skeletal muscle. J Diabetes Res. 2014; 2014: 765784. doi: 10.1155/2014/765784
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Diabetes Research (DR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
